Cargando…
Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance
Herceptin (trastuzumab) is a recombinant, humanized, monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2) and is used in the treatment of HER2-positive breast and gastric cancers. However, it carries a risk of cardiotoxicity, manifesting as left ventricular (LV) systo...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898877/ https://www.ncbi.nlm.nih.gov/pubmed/35265371 http://dx.doi.org/10.1155/2022/1910841 |